758sek
-2,4 %
Date:2024-06-19Time:17:29:39Latest report:Q1-2024List:Small CapTicker:SEZI
Market Cap:907 msekEnterprise Value:802 msekNet Sales:40,6 msekEarnings:-131,3 msekEmployees:0ISIN:SE0002478776

Ratios

10-year key figure history for Senzime turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Senzime with index and moving average MA50 and MA200.

Stockprice:7,58
MA50:6,79
MA200:6,78
Price/MA200:11,7 %
RSI (14):61,2
Price/MA50:11,7 %

Description

Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its products include TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States of America which generates key revenue, Europe/Oceania, and Asia.

Medical Equipment